Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington, shared a Leukemia Journal’s post on X, adding:
“Nicest SMM commentary I’ve seen in this new era – thanks Ola Landgren, Leukemia Journal.
Pt preferences factor heavily into dara or not, but even better stratification tools coming ‘R/R SMM‘ remains a self-created nomenclature challenge… this is genomic MM! Eloquent points.”
Quoting Leukemia Journal’s post:
“Smoldering multiple myeloma in transition: redefining early myeloma in the modern era | Leukemia Approval of Daratumumab as early intervention marks a pivotal moment.”
Title: Smoldering multiple myeloma in transition: redefining early myeloma in the modern era
Author: Ola Landgren
Other articles featuring Rahul Banerjee and Leukemia Journal OncoDaily.
